Zeke Capital Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-1,537
| Closed | -$262K | – | 325 |
|
2020
Q4 | $262K | Sell |
1,537
-106
| -6% | -$18.1K | 0.02% | 213 |
|
2020
Q3 | $231K | Buy |
1,643
+215
| +15% | +$30.2K | 0.03% | 193 |
|
2020
Q2 | $229K | Buy |
+1,428
| New | +$229K | 0.04% | 169 |
|
2020
Q1 | – | Sell |
-5,343
| Closed | -$689K | – | 468 |
|
2019
Q4 | $689K | Buy |
5,343
+491
| +10% | +$63.3K | 0.06% | 304 |
|
2019
Q3 | $365K | Sell |
4,852
-733
| -13% | -$55.1K | 0.03% | 416 |
|
2019
Q2 | $849K | Sell |
5,585
-917
| -14% | -$139K | 0.08% | 225 |
|
2019
Q1 | $775K | Sell |
6,502
-2,506
| -28% | -$299K | 0.07% | 241 |
|
2018
Q4 | $983K | Buy |
9,008
+4,408
| +96% | +$481K | 0.09% | 205 |
|
2018
Q3 | $743K | Buy |
4,600
+1,263
| +38% | +$204K | 0.06% | 305 |
|
2018
Q2 | $441K | Buy |
3,337
+88
| +3% | +$11.6K | 0.04% | 327 |
|
2018
Q1 | $241K | Buy |
+3,249
| New | +$241K | 0.02% | 510 |
|